(Q24244127)

3

0 references

Sally Merry

2

object named as

Sally N Merry

0 references

author name string

Sarah E Hetrick

1

0 references

Per Sindahl

Cochrane Database of Systematic Reviews

4

0 references

publication date

18 July 2007

0 references

published in

0 references

cites work

Fluoxetine in child and adolescent depression: acute and maintenance treatment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

The Kutcher Adolescent Depression Scale: assessment of its evaluative properties over the course of an 8-week pediatric pharmacotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Treatment for Adolescents With Depression Study (TADS): Rationale, Design, and Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Suicidal attempts among older adolescents: prevalence and co-occurrence with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Childhood and adolescent depression. II: Research in clinical populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Relation between anxiety and depressive disorders in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Childhood and adolescent depression: a review of the past 10 years. Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Psychopathology and its relationship to suicidal ideation in childhood and adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Psychiatric risk factors for adolescent suicide: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Clinical practice. Adolescent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Diagnosis and measurement of adolescent depression: a review of commonly utilized instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Phenomenology of major depression from childhood through adulthood: analysis of three studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Review of the efficacy and safety of antidepressants in youth depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Fluoxetine versus other types of pharmacotherapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Pharmacological treatment of adolescent major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Recent developments and current controversies in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Psychiatric symptoms and their relationship to suicidal ideation in a high-risk adolescent community sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Phenomenology, psychosocial correlates, and treatment seeking in major depression and dysthymia of adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Expanding the black box - depression, antidepressants, and the risk of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Incidence of major depressive disorder and dysthymia in young adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

The relationship between antidepressant medication use and rate of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

A meta-analysis of the effects of cognitive therapy in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Antidepressants and suicide: what is the balance of benefit and harm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Adult outcomes of childhood and adolescent depression. I. Psychiatric status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Tricyclic drugs for depression in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Suicide prevention – a medical breakthrough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Paroxetine in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Efficacy and safety of antidepressants for children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Are child-, adolescent-, and adult-onset depression one and the same disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Family study of subthreshold depressive symptoms: risk factor for MDD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

The prevalence and co-morbidity of subthreshold psychiatric conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Anti-depressants, suicide, and drug regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Depressive disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

How effective are treatments for child and adolescent depression? A meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Efficacy of antidepressants in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Ten-year review of rating scales. II: Scales for internalizing disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

A black-box warning for antidepressants in children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Unipolar depression in adolescents: clinical outcome in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Subsyndromal symptomatic depression: a new concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Global assessment of psychosocial functioning in child and adolescent psychiatry. A review of three unidimensional scales (CGAS, GAF, GAPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Psychiatric Diagnosis in Child and Adolescent Suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

How Can We Know Whether Antidepressants Increase Suicide Risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Suicide risk during antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Is clinical depression distinct from subthreshold depressive symptoms? A review of the continuity issue in depression research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

National estimates of antidepressant medication use among U.S. children, 1997-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Pharmacotherapy for major depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Depressed Adolescents Grown Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Effects of psychotherapy for depression in children and adolescents: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Treatment options in the management of adolescent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Suicide risk and the SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Ten-year review of rating scales, VII: scales assessing functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

Individual, Family, School, and Community Risk and Protective Factors for Depressive Symptoms in Adolescents: A Comparison of Risk Profiles for Substance Use and Depressive Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

The Risk for Early-Adulthood Anxiety and Depressive Disorders in Adolescents With Anxiety and Depressive Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

The effects of extended evaluation on depressive symptoms in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study1Presented at the American Academy of Child and Adolescent Psychiatry 42nd Annual Meeting, New Orleans, LA, 19 October 19

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

Depression in adolescence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

Symptoms versus a diagnosis of depression: differences in psychosocial functioning

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

The outcome of adolescent depression in the Ontario Child Health Study follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

Recurrence of Major Depressive Disorder in Hospitalized Children and Adolescents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

Fluvoxamine in the treatment of depressive illness in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

The Maudsley long-term follow-up of child and adolescent depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

The Maudsley long-term follow-up of child and adolescent depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021

Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004851.PUB2

7 January 2021